China’s NMPA Proposes Elimination of Country-of-Origin Approval Requirement for Medical Devices
The National Medical Products Administration (NMPA) in China has released a draft Medical Device Administrative Law (MDAL) and is soliciting comments from stakeholders. The MDAL is a novel promulgation in China. A notable proposed change is the elimination of the existing country... Read More